Topic 376 - phase I - non-invasive subtyping of aggressive tumor and its environment - moonshot 09/24/2018 - 06/24/2019
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91018C00025
- Awardee
-
Inlighta Biosciences L.L.C. UEI KCSBM7ASMA34
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $298,230
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Pre-Solicitation · N43CO8701294 · Posted Jun 29, 2017
- Contract value 100% obligated
- $298,230.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 10 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Marietta, GA 30068, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $298,230 |
About this award
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (NCI) to Inlighta Biosciences L.L.C., a woman-owned small business. The $298,230.00 firm fixed-price contract is for a Phase I Small Business Innovation Research (SBIR) project titled "Non-Invasive Subtyping of Aggressive Tumor and Its Environment" as part of the NCI Cancer Moonshot initiative. The original solicitation was issued under the NIH/CDC SBIR Contract Solicitation PHS 2018-1, which sought proposals from small businesses to conduct innovative research supporting the objectives of the NIH and Centers for Disease Control and Prevention. This contract has a total small business set-aside designation.
Quick answers
Who was awarded contract 75N91018C00025?
75N91018C00025 was awarded to Inlighta Biosciences L.L.C. by National Cancer Institute (National Institutes of Health) on September 13, 2018.
How much is contract 75N91018C00025 worth?
The government has obligated $298,230 on 75N91018C00025.
Was contract 75N91018C00025 competed?
The extent of competition for 75N91018C00025 was full and open competition after exclusion of sources. The government received 10 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award